| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.45 | 0.01 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |